# Hanmi Financial Corp: overview

HAFC · Nasdaq · CIK 1109242 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hafc.md) · [Financials](/companies/hafc/financials.md) · [Filings](/companies/hafc/filings.md) · [Insiders](/companies/hafc/insiders.md)

Latest reported revenue: [$72.2m](/filings/0001193125-26-339697.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-339697).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [58.5](/filings/0001193125-25-271719.md) | [60.8 d](/filings/0001193125-26-082425.md) | [62.8](/filings/0001193125-26-214092.md) | [65.2](/filings/0001193125-26-339697.md) | [71.0](/filings/0001193125-25-271719.md) | [71.2 d](/filings/0001193125-26-082425.md) | [71.7](/filings/0001193125-26-214092.md) | [72.2](/filings/0001193125-26-339697.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [25.5%](/filings/0001193125-25-271719.md) | [29.1% d](/filings/0001193125-26-082425.md) | [28.1%](/filings/0001193125-26-214092.md) | [23.2%](/filings/0001193125-26-339697.md) | [31.1%](/filings/0001193125-25-271719.md) | [29.8% d](/filings/0001193125-26-082425.md) | [31.4%](/filings/0001193125-26-214092.md) | [32.6%](/filings/0001193125-26-339697.md) |
| Net margin | % | [25.5%](/filings/0001193125-25-271719.md) | [29.1% d](/filings/0001193125-26-082425.md) | [28.1%](/filings/0001193125-26-214092.md) | [23.2%](/filings/0001193125-26-339697.md) | [31.1%](/filings/0001193125-25-271719.md) | [29.8% d](/filings/0001193125-26-082425.md) | [31.4%](/filings/0001193125-26-214092.md) | [32.6%](/filings/0001193125-26-339697.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001193125-25-271719.md) | not reported | [0.58](/filings/0001193125-26-214092.md) | [0.50](/filings/0001193125-26-339697.md) | [0.73](/filings/0001193125-25-271719.md) | not reported | [0.75](/filings/0001193125-26-214092.md) | [0.79](/filings/0001193125-26-339697.md) |
| Free cash flow | $m | [6.5 d](/filings/0001193125-25-271719.md) | [13.0 d](/filings/0001193125-26-082425.md) | [26.1](/filings/0001193125-26-214092.md) | [(19.0) d](/filings/0001193125-26-339697.md) | [145 d](/filings/0001193125-25-271719.md) | [51.3 d](/filings/0001193125-26-082425.md) | [23.4](/filings/0001193125-26-214092.md) | [(9.9) d](/filings/0001193125-26-339697.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [272](/filings/0000950170-25-029782.md) | [255](/filings/0001193125-26-082425.md) | [234](/filings/0001193125-26-082425.md) | [270](/filings/0001193125-26-082425.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | [37.3%](/filings/0000950170-25-029782.md) | [31.3%](/filings/0001193125-26-082425.md) | [26.5%](/filings/0001193125-26-082425.md) | [28.2%](/filings/0001193125-26-082425.md) |
| Net margin | % | not reported | [37.3%](/filings/0000950170-25-029782.md) | [31.3%](/filings/0001193125-26-082425.md) | [26.5%](/filings/0001193125-26-082425.md) | [28.2%](/filings/0001193125-26-082425.md) |
| Diluted EPS | $ per share | [3.22](/filings/0000950170-24-022986.md) | [3.32](/filings/0000950170-25-029782.md) | [2.62](/filings/0001193125-26-082425.md) | [2.05](/filings/0001193125-26-082425.md) | [2.51](/filings/0001193125-26-082425.md) |
| Free cash flow | $m | [91.0](/filings/0000950170-24-022986.md) | [145](/filings/0000950170-25-029782.md) | [107](/filings/0001193125-26-082425.md) | [49.9](/filings/0001193125-26-082425.md) | [204](/filings/0001193125-26-082425.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hafc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $142.2m | 4,388,542 |  | Reduced −56 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $57.9m | 1,786,314 |  | Added +25,459 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $51.0m | 1,575,567 |  | Added +35,152 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $42.7m | 1,317,877 |  | Added +10,329 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $36.0m | 1,110,109 |  | Added +81,896 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $33.8m | 1,043,542 |  | Added +82,995 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $28.3m | 874,145 |  | Reduced −30,063 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $25.7m | 793,267 |  | Added +65,011 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $25.1m | 773,601 |  | Added +28,542 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $17.7m | 545,862 |  | Reduced −69,935 |

## Recent filings

[All 1,041 filings](/companies/hafc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 08:00 ET | [8-K](/filings/0001171843-26-006959.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-006959 |
| 2026-10-27 | 16:06 ET | [8-K](/filings/0001171843-26-006857.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006857 |
| 2026-08-17 | 08:30 ET | [8-K](/filings/0001171843-26-005579.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005579 |
| 2026-08-11 | 08:00 ET | [8-K](/filings/0001171843-26-005408.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005408 |
| 2026-08-07 | 12:06 ET | [10-Q](/filings/0001193125-26-339697.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339697 |
| 2026-07-31 | 17:48 ET | [8-K](/filings/0001193125-26-326406.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326406 |
| 2026-07-27 | 16:06 ET | [8-K](/filings/0001171843-26-004897.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004897 |
| 2026-07-23 | 08:00 ET | [8-K](/filings/0001171843-26-004849.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-004849 |
| 2026-07-21 | 16:29 ET | [8-K](/filings/0001171843-26-004799.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004799 |
| 2026-05-28 | 18:15 ET | [8-K](/filings/0001171843-26-003730.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-003730 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-082425.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/f98aa40a-7969-49d7-a8de-c6a88752ddcf)

## About the filer

- CIK: 1109242
- Tickers: HAFC
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:02 ET. No prices; not investment advice.